The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Cellerant Therapeutics Inc

  • Contact Person: Ram Mandalam
  • Contact Phone: 650-232-2122
  • Contact Email: rmandalam@cellerant.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • For Profit Organization
  • Industries Served: Biological Product (except Diagnostic) Manufacturing
  • Product Areas: R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), LIFE SCIENCES (APPLIED/EXPLORATORY)

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $36,391,720 - Saturday the 1st of August 2015
    Office Of Assistant Secretary For Administration And Management
    OFF ASST SEC ADM AND MGMT
    ADVANCED DEVELOPMENT OF THERAPEUTICS FOR TREATING NEUTROPENIA RESULTING FROM ACUTE EXPOSURE TO IONIZING RADIATION CAN 1990987 CAN 1990087
  • $194,467 - Thursday the 14th of May 2015
    National Institutes Of Health
    NIH, NCI, OD OM OA OFC ACQUISITIONS
    IGF::OT::IGF OTHER FUNCTIONS - R&D BIOMEDICAL (BASIC RESEARCH)

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.